BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, December 28, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

In the clinic for June 12, 2020

June 12, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Creatv Microtech.
Read More

Financings for June 12, 2020

June 12, 2020
Med-tech firms raising money in public or private financings, including: Burning Rock Biotech, Neovasc.
Read More

Appointments and advancements for June 12, 2020

June 12, 2020
New hires and promotions in the med-tech industry, including: 3Shape, Bigfoot Medical.
Read More

Conference data for June 12, 2020: European Hematology Association

June 12, 2020
New and updated preclinical and clinical data presented by biopharma firms at the European Hematology Association's Annual Congress, including: ADC, Agios, Alx, Apellis, Aprea, Aptose, Astrazeneca, Autolus, Beigene, Bluebird, Constellation, Crispr, Editas, Forma, Imago, Imara, Geron, Keros, Kiadis, Omeros, Oryzon, Principia, Sierra Oncology, Takeda, TG, Tolero, Vertex, X4.
Read More

Regulatory actions for June 12, 2020

June 12, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adial, Biovie, Kite, Leap, Viela, ZZ.
Read More

Other news to note for June 12, 2020

June 12, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agios, BMS, Celgene, Dcprime, Revive, Royalty, Scopus, Tonix, Trigemina.
Read More

In the clinic for June 12, 2020

June 12, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agios, Atox, Aura, Bone Therapeutics, Cytodyn, Lilly, Noveome, Novo, Octimet, Otsuka, Pulmocide, Respivant, Verrica.
Read More

Financings for June 12, 2020

June 12, 2020
Biopharmas raising money in public or private financings, including: Cerecor, Entasis Therapeutics.
Read More

Appointments and advancements for June 12, 2020

June 12, 2020
New hires and promotions in the biopharma industry, including: Twoxar, Xylocor.
Read More

Regulatory actions for June 11, 2020

June 11, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Establishment Labs, Medtronic.
Read More
Previous 1 2 … 1526 1527 1528 1529 1530 1531 1532 1533 1534 … 1724 1725 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing